FindTrial
Sign In

Improving Care for Children with Leukemia Through Occupational Therapy During Bone Marrow Transplants

Pediatric Leukemia patients undergoing Hematopoietic Stem Cell Transplant: Enhancing care through Occupational Therapy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/083803
Enrollment
20
Registered
2025-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C959- Leukemia, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient diagnosed with leukemia. 2) Patient who will be admitted for allogeneic Hematopoietic Stem cell transplantation. 3) Age range 8- 15 years. 4) Indian nationals. 5) Patient willing to take entire treatment in Tata Memorial Hospital/ ACTREC.

Exclusion criteria

Exclusion criteria: 1) Patients having history of any psychiatric illness. 2) Patients cannot see and or hear.

Design outcomes

Primary

MeasureTime frame
To assess the Occupational performance areas in pediatric leukemia patients undergoing allogeneic hematopoietic stem cell transplant using the Canadian Occupational Performance Measure (COPM). Timepoint: 8 months—

Secondary

MeasureTime frame
To assess the performance component fine motor dexterity in pediatric leukemia patients undergoing allogeneic hematopoietic stem cell transplant using Nine Hole Peg Test(9HPT).Timepoint: 8 months;To assess the performance component grip strength in pediatric leukemia patients undergoing allogeneic hematopoietic stem cell transplant using Hand Dynamometer.Timepoint: 8months;To assess the performance component- functional mobility in pediatric leukemia patients undergoing allogeneic hematopoietic stem cell transplant using Timed up and go test (TUG).Timepoint: 8 months;To assess the performance component- balance in pediatric leukemia patients undergoing allogeneic hematopoietic stem cell transplant using Paediatric Balance Scale (PBS).Timepoint: 8months;To assess the performance areas - play participation in pediatric leukemia patients undergoing allogeneic hematopoietic stem cell transplant using Takata play history. Timepoint: 8months;To assess the performance areas - schooling abilities in pediatric leukemia patients undergoing allogeneic hematopoietic stem cell transplant using a departmental semi-structured interview.Timepoint: 8months—

Countries

India

Contacts

Public ContactPriya kumari

Tata Memorial Hospital Mumbai

kumaripriyavats@gmail.com6204288248

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026